ACUTA CAPITAL PARTNERS, LLC CRNX Holdings History
ACUTA CAPITAL PARTNERS, LLC's Crinetics Pharmaceuticals Inc Holding Summary
As of 2025-03-31, ACUTA CAPITAL PARTNERS, LLC held - shares of Crinetics Pharmaceuticals Inc(CRNX), totaling N/A. This investment constitutes 0% of their stock portfolio, and ACUTA CAPITAL PARTNERS, LLC now holds 0% of the outstanding Crinetics Pharmaceuticals Inc(CRNX) stock.
The initial trade took place in 2023Q3. And since then ACUTA CAPITAL PARTNERS, LLC has made 2 purchases of CRNX, at an average price of $30.23, for a total of 150,738.00 shares. In addition, there have been 5 sales at an average price of $38.58 for 150,738.00 shares. Based on historical transaction data and CRNX's current price of $32.97, ACUTA CAPITAL PARTNERS, LLC's estimated gain on his CRNX holdings is $1.26 Mil, reflecting a 27.61% gain to date.
ACUTA CAPITAL PARTNERS, LLC CRNX ($32.97) Holding Chart
ACUTA CAPITAL PARTNERS, LLC CRNX ($32.97) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
